Tech Company Financing Transactions
Torrey Pines Medicine Funding Round
Torrey Pines Medicine secured a funding round on 7/28/2026. Investors included Blue Ocean Capital, private investors and Star Capital.
Transaction Overview
Company Name
Announced On
7/28/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support corporate development, accelerate IND filing and Phase I clinical trials for its core pipeline asset TPM004, and refine its PepTetris technology platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Shenzhen, Undisclosed
China
Shenzhen, Undisclosed
China
Phone
Undisclosed
Email Address
Not Recorded
Overview
Torrey Pines Medicine is a pre-clinical-stage biotechnology company incubated by Shenzhen Bay Laboratory, dedicated to developing next-generation ultra-long-acting peptide therapeutics for obesity, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and other chronic metabolic diseases. To address key clinical unmet needs associated with current mainstream weight-loss treatments--including gastrointestinal adverse events, muscle mass loss, poor long-term adherence, and weight regain post-discontinuation--Torrey Pines Medicine is building an end-to-end R&D engine focused on ultra-long-acting peptide novel drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Qingsong Zhu
Browse more venture capital transactions:
Prev: 7/28/2026: Claros Technologies venture capital transaction
Next: 7/28/2026: Valuemize venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs